121 related articles for article (PubMed ID: 28641638)
21. Increased serum level of interleukin-6 correlates with negative prognostic factors in extranodal NK/T-cell lymphoma.
Bao C; Zhou D; Zhu L; Qian W; Ye X
Transl Cancer Res; 2020 Apr; 9(4):2378-2389. PubMed ID: 35117598
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T-cell lymphoma.
Shen Z; Chen X; Sun C; Lu T; Shi Y; Zhang H; Ye J; Wang L; Zhu T; Miao Y; Zhang X; Wang L; Cai G; Sang W
Cancer Med; 2023 Dec; 12(23):21138-21147. PubMed ID: 37902266
[TBL] [Abstract][Full Text] [Related]
23. [Clinical Treatment and Prognosis of 61 Patients with Extranodal NK/T Cell Lymphoma].
Liu Y; Huang CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):512-517. PubMed ID: 32319388
[TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics and survival analysis of primary intestinal extranodal NK/T-cell lymphoma, nasal type].
Li Y; Wang XJ; Li YN; Wang XH; Shi YQ; Chen M
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):818-821. PubMed ID: 33190438
[No Abstract] [Full Text] [Related]
25. Clinical characteristics and prognosis of primary Waldeyer's ring and lymph node diffuse large B-cell lymphoma in the rituximab era.
Jing XM; Yu JR; Luo YK; Zhang SC; Liu JF; Li L; Wu P; Zhang ZH
Leuk Res; 2017 Sep; 60():89-93. PubMed ID: 28772206
[TBL] [Abstract][Full Text] [Related]
26. [Expression of CD7 and its correlation with prognosis in patients with NK/T-cell lymphoma].
Fu XR; Wan WJ; Sun ZC; Zhang XD; Nan FF; Ge JR; Xia YQ; Zhang MZ
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):921-926. PubMed ID: 33333695
[No Abstract] [Full Text] [Related]
27. Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.
Zhang J; Wang WD; Geng QR; Wang L; Chen XQ; Liu CC; Lv Y
PLoS One; 2014; 9(4):e94637. PubMed ID: 24722378
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of circulating exosomal PD-L1 and soluble PD-L1 in extranodal NK/T-cell lymphoma, nasal-type.
Li JW; Wei P; Guo Y; Shi D; Yu BH; Su YF; Li XQ; Zhou XY
Am J Cancer Res; 2020; 10(12):4498-4512. PubMed ID: 33415014
[TBL] [Abstract][Full Text] [Related]
29. Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.
Yang CW; Wang CW; Hong RL; Tsai CL; Yao M; Tang JL; Lin CW; Cheng AL; Kuo SH
J Radiat Res; 2017 Jan; 58(1):114-122. PubMed ID: 27534792
[TBL] [Abstract][Full Text] [Related]
30. Short-Course Versus Long-Course Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study.
Li J; Li Y; Zhong M; Liu X; Song Y; Li J; Li K; Yi P
Med Sci Monit; 2018 May; 24():2683-2692. PubMed ID: 29712887
[TBL] [Abstract][Full Text] [Related]
31. [Clinical Significance of Detecting CD4
Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.
Ding W; Wang J; Zhao S; Yang Q; Sun H; Yan J; Gao L; Yao W; Zhang W; Liu W
Pathol Res Pract; 2015 Jul; 211(7):544-9. PubMed ID: 25953340
[TBL] [Abstract][Full Text] [Related]
33. Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Li ZM; Xia Y; Huang JJ; Huang HQ; Xia ZJ; Lin TY; Li S; Cai XY; Wu-Xiao ZJ; Jiang WQ
PLoS One; 2013; 8(5):e64158. PubMed ID: 23724031
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of 202 cases of extranodal NK/T-cell lymphoma].
Ma C; Bo J; Liu T; Yao S; Zhao Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):999-1004. PubMed ID: 25130817
[TBL] [Abstract][Full Text] [Related]
35. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
[TBL] [Abstract][Full Text] [Related]
36. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH;
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920
[TBL] [Abstract][Full Text] [Related]
37. [Expression of PDGFRA and CMYC in extranodal NK/T-cell lymphoma and their prognostic implications].
Chen YP; Zhu WF; Lin JY; He TM; Ma HM; Lu JP; Ye XA; Xu CW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):825-830. PubMed ID: 28056296
[No Abstract] [Full Text] [Related]
38. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
39. CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.
Wang L; Wang H; Li PF; Lu Y; Xia ZJ; Huang HQ; Zhang YJ
Ann Hematol; 2015 Aug; 94(8):1381-8. PubMed ID: 25865943
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck.
Suh C; Kang YK; Roh JL; Kim MR; Kim JS; Huh J; Lee JH; Jang YJ; Lee BJ
J Nucl Med; 2008 Nov; 49(11):1783-9. PubMed ID: 18927319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
